Brian Adams - 07 Jun 2021 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role: General Counsel
Signature: /s/ Brian Adams
Issuer symbol: RLAY
Transactions as of: 07 Jun 2021
Net transactions value: -$200,720
Form type: 4
Filing time: 09 Jun 2021, 20:37:39 UTC
Next filing: 30 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RLAY	Common Stock	Options Exercise	$26,780	+6,500	+25%	$4.12	32,370	07 Jun 2021	Direct	F1
transaction	RLAY	Common Stock	Sale	$227,500	-6,500	-20%	$35.00	25,870	07 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RLAY	Stock Option (Right to Buy)	Options Exercise	$0	-6,500	-4.1%	$0.000000	153,786	07 Jun 2021	Common Stock	6,500	$4.12	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020.
F2	Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.